An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

Clinical trial of people destined to develop early-onset Alzheimer’s disease shows eliminating amyloid from brain.

Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains<a class="excerpt-read-more" href=" More ...

Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

You might not remember what you ate for breakfast yesterday, but your body certainly does. For better or worse, your dietary ...

A new study suggests a promising alternative to previous attempts to remove the sticky, toxic amyloid beta plaques from brains with Alzheimer's Disease: enhancing the brain's own immune cells to clear ...

AND THIS IS ALSO VERY RARE. THE MAIN FEATURES ARE PLAQUES AND TANGLES IN THE BRAIN. ANOTHER FEATURE IS A LOSS OF CONNECTION BETWEEN NERVE CELLS OR NEURONS IN THE BRAIN. SO THE BIG QUESTION IS HOW ...

The communication system between your gut and brain is called the gut-brain axis. They’re connected both physically and biochemically in a number of different ways. They may even influence each ...

It has been highly studied because its breakdown creates amyloid-β peptides, which are often present in plaques in the brains of people with Alzheimer’s disease. What accelerates brain ageing?